Philip E Castle (Philip Castle)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 20

Top Topics

Polycystic Ovary Syndrome

Cervical Cancer Screening

Top Venues

JCO global oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer prevention research (Philadelphia, Pa.)

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Samantha H Batman, Ricardina Rangeiro, Eliane Monteiro, Dercia Changule, Siro Daud, Magda Ribeiro, Edgar Tsambe, Celso Bila, Nafissa Bique Osman, Carla Carrilho, Andrea Neves, Hira Atif, Celda De Jesus, Arlete Mariano, Renato Moretti Marques, Marcelo Vieira, Geórgia Fontes Cintra, André Lopes de Faria E Silva, Jean Claude Batware, Elvira Luis, Surbhi Grover, Ellen Baker, Bryan Fellman, Jane Montealegre, Philip E Castle, Jose Jeronimo, Elizabeth Yu Chiao, Cesaltina Lorenzoni, Kathleen M Schmeler, Mila Pontremoli Salcedo
Expanding Cervical Cancer Screening in Mozambique: Challenges Associated With Diagnosing and Treating Cervical Cancer. JCO global oncology 9 (2023)
Ruth B Etzioni, Philip E Castle
Shopping for New Cancer Screening Tests. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Montserrat Soler, Karla Alfaro, Rachel J Masch, Gabriel Conzuelo Rodriguez, Xinfeng Qu, Suhui Wu, Jingfen Sun, Dayana Marinela Hernández Jovel, Luis Jairo Bonilla-Osma, Luis Orlando Puentes, Rául Murillo, Todd A Alonzo, Juan C Felix, Philip E Castle, Miriam Cremer
Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial. JCO global oncology 8 (2022)
Camryn M Cohen, Nicolas Wenstzensen, Philip E Castle, Mark Schiffman, Rosemary Zuna, Rebecca C Arend, Megan A Clarke
Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Montserrat Soler, Karla Alfaro, Rachel J Masch, Gabriel Conzuelo Rodriguez, Xinfeng Qu, Suhui Wu, Jingfen Sun, Dayana Marinela Hernández Jovel, Luis Jairo Bonilla-Osma, Luis Orlando Puentes, Rául Murillo, Todd A Alonzo, Juan C Felix, Philip E Castle, Miriam Cremer
Safety and Acceptability of Three Ablation Treatments for High-Grade Cervical Precancer: Early Data From a Randomized Noninferiority Clinical Trial. JCO global oncology 8 (2022)
Philip E Castle, Nicolas Wenstzensen
Clarifying the Equivocal Diagnosis of Cervical Intraepithelial Neoplasia 2: Still a Work in Progress. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Howard D Strickler, Marla J Keller, Nancy A Hessol, Isam-Eldin Eltoum, Mark H Einstein, Philip E Castle, L Stewart Massad, Lisa Flowers, Lisa Rahangdale, Jessica M Atrio, Catalina Ramirez, Howard Minkoff, Adaora A Adimora, Igho Ofotokun, Christine Colie, Megan J Huchko, Margaret Fischl, Rodney Wright, Gypsyamber D'Souza, Jason Leider, Olga Diaz, Lorraine Sanchez-Keeland, Sadeep Shrestha, Xianhong Xie, Xiaonan Xue, Kathryn Anastos, Joel M Palefsky, Robert D Burk
Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 72 (9) (2021)
Boshen Jiao, Roman Gulati, Hormuzd A Katki, Philip E Castle, Ruth Etzioni
A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
Julia C Gage, Tina Raine-Bennett, Mark Schiffman, Megan A Clarke, Li C Cheung, Nancy E Poitras, Nicole E Varnado, Hormuzd A Katki, Philip E Castle, Brian Befano, Malini Chandra, Greg Rydzak, Thomas S Lorey, Nicolas Wentzensen
The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
Brady Hunt, José Humberto Tavares Guerreiro Fregnani, David Brenes, Richard A Schwarz, Mila P Salcedo, Júlio César Possati-Resende, Márcio Antoniazzi, Bruno de Oliveira Fonseca, Iara Viana Vidigal Santana, Graziela de Macêdo Matsushita, Philip E Castle, Kathleen M Schmeler, Rebecca R Richards-Kortum
Cervical lesion assessment using real-time microendoscopy image analysis in Brazil: The CLARA study. International journal of cancer 149 (2) (2021)
Philip E Castle
Is It Time for Risk-based Screening Guidelines for the Prevention of Anal Cancer? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (1) (2021)
Karla Alfaro, Mauricio Maza, Juan C Felix, Julia C Gage, Philip E Castle, Todd A Alonzo, Andrea Chacón, Enrique González, Montserrat Soler, Gabriel Conzuelo, Rachel J Masch, Miriam Cremer
Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing-Based Cervical Screen-and-Treat Program in El Salvador. JCO global oncology 6 (2021)
Philip E Castle, Rogers Ajeh, Anastase Dzudie, Ernestine Kendowo, Norbert Fuhngwa, Andre Gaetan Simo-Wambo, Denis Nsame, Enow Orock, Tiffany M Hebert, Amanda J Pierz, Daniel Murokora, Kathryn Anastos, Adebola Adedimeji
A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon. Infectious agents and cancer 15 (2020)
Mykhaylo Usyk, Christine P Zolnik, Philip E Castle, Carolina Porras, Rolando Herrero, Ana Gradissimo, Paula Gonzalez, Mahboobeh Safaeian, Mark Schiffman, Meredith Yeager, null null
Cervicovaginal microbiome and natural history of HPV in a longitudinal study. PLoS pathogens 16 (3) (2020)
Philip E Castle, Amanda J Pierz, Rachael Adcock, Shagufta Aslam, Partha S Basu, Jerome L Belinson, Jack M Cuzick, Mariam El-Zein, Catterina Ferreccio, Cynthia Firnhaber, Eduardo L Franco, Patti E Gravitt, Sandra D Isidean, John Lin, Salaheddin M Mahmud, Joseph Monsonego, Richard Muwonge, Samuel Ratnam, Mahboobeh Safaeian, Mark Schiffman, Jennifer S Smith, Avril Swarts, Thomas C Wright, Vanessa Van De Wyngard, Long Fu Xi
A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers. Cancer prevention research (Philadelphia, Pa.) 13 (10) (2020)
Haejin In, Ian Solsky, Philip E Castle, Clyde B Schechter, Michael Parides, Patricia Friedmann, Judith Wylie-Rosett, M Margaret Kemeny, Bruce D Rapkin
Utilizing Cultural and Ethnic Variables in Screening Models to Identify Individuals at High Risk for Gastric Cancer: A Pilot Study. Cancer prevention research (Philadelphia, Pa.) 13 (8) (2020)
Tomás Ruiz-López, Sagar Sen, Elisabeth Jakobsen, Ameli Tropé, Philip E Castle, Bo Terning Hansen, Mari Nygård
FightHPV: Design and Evaluation of a Mobile Game to Raise Awareness About Human Papillomavirus and Nudge People to Take Action Against Cervical Cancer. JMIR serious games 7 (2) (2019)
Philip E Castle, Vânia R S Silva, Marcia E L Consolaro, Nádia Kienen, Lorna Bittencourt, Sandra M Pelloso, Edward E Partridge, Amanda Pierz, Camila B Dartibale, Nelson S Uchimura, Isabel C Scarinci
Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil. Cancer prevention research (Philadelphia, Pa.) 12 (3) (2019)
Rebecca Landy, Mark Schiffman, Peter D Sasieni, Li C Cheung, Hormuzd A Katki, Greg Rydzak, Nicolas Wentzensen, Nancy E Poitras, Thomas Lorey, Walter K Kinney, Philip E Castle
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting. International journal of cancer 146 (3) (2019)
Philip E Castle, Meredith Yeager, Leslie Stewart Massad, Isam-Eldin Eltoum, Charles B Hall, Nancy A Hessol, Kathryn Anastos, Xianhong Xie, Howard Minkoff, Xiaonan Xue, Gypsyamber D'Souza, Lisa Flowers, Christine Colie, Lisa Rahangdale, Margaret A Fischl, Joel M Palefsky, Howard D Strickler
Epidemiological evidence that common HPV types may be common because of their ability to evade immune surveillance: Results from the Women's Interagency HIV study. International journal of cancer 146 (12) (2019)